Correspondence re: Feyler et al., Point: Myeloperoxidase −463G → a polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The Myeloperoxidase −463G → a polymorphism does not decrease lung cancer susceptibility in Caucasians. 11: 1555-1559, 2002

• Verfasst von: Dally, Heike [VerfasserIn]
• Verfasst von: Bartsch, Helmut [VerfasserIn]
• Verfasst von: Risch, Angela [VerfasserIn]
• Titel: Correspondence re: Feyler et al., Point: Myeloperoxidase −463G → a polymorphism and lung cancer risk. Cancer Epidemiol. Biomark. Prev., 11: 1550-1554, 2002, and Xu et al., Counterpoint: The Myeloperoxidase −463G → a polymorphism does not decrease lung cancer susceptibility in Caucasians. 11: 1555-1559, 2002
• Verf.angabe: Heike Dally, Helmut Bartsch and Angela Risch
• Jahr: 2003
• Umfang: 1 S.
• Fussnoten: Im Titel ist -463 jeweils hochgestellt ; Gesehen am 16.12.2020
• Titel Quelle: Enthalten in: Cancer epidemiology, biomarkers & prevention
• Ort Quelle: Philadelphia, Pa. : AACR, 1991
• Jahr Quelle: 2003
• Band/Heft Quelle: 12(2003), 7, Seite 683
• ISSN Quelle: 1538-7755
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1743034024

Abstract

Since 1997, nine studies on MPO-463 genotype and lung cancer risk in Caucasians have been published. A significant reduction of the levels of benzo( a )pyrene diol epoxide-DNA adducts in human skin after coal tar treatment for MPO-A allele carriers has also been shown [(1)][1] . This indicates that